Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Copyright 2023 – Finance News Network
Source: Finance News Network
16 May 2023 - ABx Group Limited (ASX:ABX) CEO and Managing Director Dr Mark Cooksey discusses the advantages of ionic clay rare earths deposits, the company's exploration program, its plays for a scoping study and a pilot plant, and its new process to develop fluorine from aluminium smelting waste.
Read More07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
Read More27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
Read More03 Jun 2024 - Chris Gosselin interviews Dan Nicolaides on how Digital Asset Funds Management uses crypto market volatility for stable returns and risk management.
Read More05 Oct 2022 - QX Resources Limited (ASX:QXR) Managing Director Stephen Promnitz discusses what brought him to QXR, and the company's assets and development stage.
Read More01 Dec 2021 - MinRex Resources Limited (ASX:MRR) Non-Executive Director George Karageorge provides an update on the company's gold and base metals projects in WA and the Lachlan Ford Belt, NSW and its recently acquired lithium projects in the Pilbara.
Read More21 Dec 2023 - Dive into Laramide Resources' (ASX:LAM) uranium ventures with insights from Non-Executive Chairman John G Booth. He discusses flagship projects, grants and developments in Australia and the US.
Read More07 Jul 2021 - Knosys Limited (ASX:KNO Managing Director John Thompson provides an overview of the recent acquisition of LIBERO, a leading library management software business.
Read More31 Mar 2020 - Cynata Therapeutics Limited (ASX:CYP) Managing Director, Dr Ross MacDonald, talks 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company's Cymerus cell therapy platform.
Read More21 Feb 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses progress towards construction of a lithium refinery.
Read More
